These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 7083214)

  • 1. Historical controls, data banks, and randomized trials in clinical research: a review.
    Fleming TR
    Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategy and alternate randomized designs in cancer clinical trials.
    Zelen M
    Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantages and drawbacks of the Zelen design for randomized clinical trials.
    Horwitz RI; Feinstein AR
    J Clin Pharmacol New Drugs; 1980 Jul; 20(7):425-7. PubMed ID: 11658484
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized clinical trials and research strategy.
    Simon R
    Cancer Treat Rep; 1982 May; 66(5):1083-7. PubMed ID: 7083212
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity and specificity of clinical trials. Randomized v historical controls.
    Sacks HS; Chalmers TC; Smith H
    Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trials.
    Fielder J
    IEEE Eng Med Biol Mag; 1994; 13(1):136-138, 141. PubMed ID: 11653269
    [No Abstract]   [Full Text] [Related]  

  • 7. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-2-3):99-103. PubMed ID: 11650154
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. I. A general overview.
    Shuster JJ; Krischer JP; Boyett JM
    Am J Pediatr Hematol Oncol; 1985; 7(1):57-63. PubMed ID: 4037244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages and drawbacks of the Zelen design for randomized clinical trials.
    Horwitz RI; Feinstein AR
    J Clin Pharmacol; 1980 Jul; 20(7):425-7. PubMed ID: 7430410
    [No Abstract]   [Full Text] [Related]  

  • 10. The doctor's dilemma: physician participation in randomized clinical trials.
    Taylor KM
    Cancer Treat Rep; 1985 Oct; 69(10):1095-100. PubMed ID: 4042089
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo controls are not good science.
    Weijer C; Appelbaum P
    IRB; 1996; 18(5):8-10. PubMed ID: 11654741
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials:randomization before consent.
    Armstrong PW; Watts DG
    Biomedicine; 1981 Sep; 34(2):65-6. PubMed ID: 7284544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 15. The patient-physician relationship in clinical trials: an ethical dilemma?
    Hill TP
    Mak Rounds Health Faith Ethics; 1996 Jun; 1(19):5-7. PubMed ID: 11654392
    [No Abstract]   [Full Text] [Related]  

  • 16. The "ethics of evidence" and randomized controlled trials.
    Truog RD; Arnold JH
    J Clin Ethics; 1992; 3(1):65-7. PubMed ID: 11643058
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics and errors of clinical trials and the role and place of different types of trial: introduction.
    Mathé G; Reizenstein P
    Drugs Exp Clin Res; 1986; 12(1-2-3):1-9. PubMed ID: 11650151
    [No Abstract]   [Full Text] [Related]  

  • 19. Research ethics, part 1: randomized clinical trials.
    Oberst MT
    Cancer Nurs; 1979 Oct; 2(4):385-6. PubMed ID: 11662896
    [No Abstract]   [Full Text] [Related]  

  • 20. Data monitoring committees: the moral case for maximum feasible independence.
    Walters L
    Stat Med; 1993 Mar; 12(5-6):575-80. PubMed ID: 11659537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.